A rare case of SRD5A3‐CDG in a patient with ataxia and telangiectasia: A case report

Sayyed Hesamedin Nabavizadeh,Rafat Noeiaghdam,Leila Johari,Seyed Ali Hosseini,Hossein Esmaeilzadeh,Soheila Sadat Alyasin
DOI: https://doi.org/10.1002/ccr3.6564
2022-11-01
Clinical Case Reports
Abstract:Steroid 5α-reductase type 3 congenital disorder of glycosylation (SRD5A3-CDG) is an extremely rare congenital disease. Common manifestations are developmental delay, intellectual disability, ophthalmological abnormalities, cerebellar abnormalities, ataxia, and hypotonia. Here, we discuss a seven-year-old boy with SRD5A3-CDG (homozygous variant c.57G>A [p.Trp19Ter]), featuring the unprecedented finding of telangiectasia.
What problem does this paper attempt to address?